GL1X · GenesisL1 explorer

MolNFT v1 · #172119 · protein

Crystal structure of SARS COV2 main protease in complex with inhibitor telaprevir

6ZRT: “Crystal structure of SARS COV2 main protease in complex with inhibitor telaprevir”. X-ray diffraction, 1 ligand (SV6), 4 pockets (best druggability 0.53). MolNFT v1 #172119 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
6ZRT
Type
protein
Length
304 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Main protease
EC
3.4.19.12, 3.4.22.-, 3.4.22.69, 2.7.7.48, 3.6.4.12, 3.6.4.13, 3.1.13.-, 3.1.-.-, 2.1.1.-
UniProt
P0DTD1
Ligands
SV6
Pockets
4 · best druggability 0.53

Structure

x-ray diffraction · 1 distinct chain · 27% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMain protease (EC 3.4.19.12, 3.4.22.-, 3.4.22.69, 2.7.7.48, 3.6.4.12, 3.6.4.13, 3.1.13.-, 3.1.-.-, 2.1.1.-)protein30427% helix, 29% strandP0DTD1

Ligands and binding sites

  • SV6 · (1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide · ligand · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12320.530.7728SV6
2990.490.8120DMS
3630.350.7814empty
4860.350.7515empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 6ZRT · Crystal structure of SARS CoV2 main protease in complex with inhibitor Telaprevir · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.